Telmisartan/ramiprilAlternative Names: Ramipril/telmisartan; Telmisartan/ramipril FDC - Boehringer Ingelheim
Latest Information Update: 02 Sep 2014
At a glance
- Originator Boehringer Ingelheim
- Class Antihypertensives; Benzimidazoles; Benzoates; Heterocyclic bicyclo compounds
- Mechanism of Action ACE inhibitors; Angiotensin type 1 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cardiovascular disorders; Hypertension